查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710948

2025年全球植入式神经刺激设备市场报告

Implantable Neurostimulation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年植入式神经刺激设备市场将快速成长。到2029年，这一数字将成长至145.3亿美元，年复合成长率（CAGR）为10.8%。预测期内的增长归因于神经系统疾病患病率上升、文明病患病率上升、认识度提高、脊髓损伤数量增加以及医疗保健支出增加。预测期内的关键趋势包括感测技术、神经刺激技术、技术先进产品、闭合迴路系统的结合以及无线技术的整合等技术的不断进步。

神经系统疾病盛行率的不断上升预计将推动植入式神经刺激设备市场的未来成长。神经病变是一种影响神经系统结构或功能的疾病，导致瘫痪、癫痫和认知障碍等多种症状。高血压、发育异常、创伤和损伤等因素导致这些疾病的检出率增加。当其他治疗方法无效或不充分时，植入式神经刺激设备可用于调节神经活动并缓解症状。例如，美国非营利组织阿兹海默症症协会报告称，到2024年，大约有690万65岁及以上的美国将患有阿兹海默症，其中73%的人年龄在75岁或以上。预计到 2050 年，这一数字将上升至 1,270 万。因此，神经系统疾病盛行率的上升预计将推动植入式神经刺激设备市场的成长。

植入式神经刺激设备市场的关键参与者正在开发先进技术，例如脊髓刺激 (SCS) 系统，以解决慢性疼痛问题。 SCS 系统是医疗设备，它使用电脉衝来调节脊髓中的神经活动，在其他治疗方法失败时缓解疼痛并改善患者的生活品质。例如，2022年12月，美国医疗设备製造商雅培（Abbott）的Eterna脊髓刺激（SCS）系统获得了FDA核准。 Eterna SCS 是市面上最小的可充电植入式脊髓刺激设备，旨在提供最大的舒适度。它采用雅培的 BurstDR 刺激技术，复製自然的大脑放电模式以增强疼痛缓解，并且比传统的刺痛刺激更受 87% 患者的青睐。 Eterna 凭藉其 Xtend 能量技术每年只需充电五次，并且凭藉其 TotalScan 技术兼容全身 MRI 扫描。它还允许您适应未来的进步而无需更换。与雅培行动应用程式集成，您可以在 iPhone 装置上即时追踪电池电量和充电状态。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球植入式神经刺激设备PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球植入式神经刺激设备市场：成长率分析
  • 全球植入式神经刺激设备市场表现：规模与成长，2019-2024
  • 全球植入式神经刺激设备市场预测：规模与成长，2024-2029 年，2034 年
  • 植入式神经刺激设备的全球总目标市场（TAM）

第六章市场区隔

  • 全球植入式神经刺激设备市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 脊髓刺激（SCS）
  • 胃电刺激（GES）
  • 深部脑部刺激（DBS）
  • 荐椎神经刺激（SNS）
  • 迷走神经刺激（VNS）
  • 其他类型
  • 全球植入式神经刺激设备市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 帕金森氏症
  • 尿失禁和大便失禁
  • 癫痫
  • 胃轻瘫
  • 其他用途
  • 全球植入式神经刺激设备市场：按最终用户、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊所
  • 门诊手术中心
  • 全球植入式神经刺激设备市场脊髓刺激 (SCS) 细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 可充电 SCS 设备
  • 不可充电的SCS设备
  • 全球植入式神经刺激设备市场胃电刺激 (GES) 细分市场（按类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 植入式胃刺激装置
  • 可调式胃刺激器
  • 全球植入式神经刺激设备市场，按深部脑部刺激 (DBS) 类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 治疗运动障碍的DBS设备
  • 用于治疗精神疾病的DBS设备
  • 全球植入式神经刺激设备市场骶荐椎神经刺激(SNS) 细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 尿失禁治疗SNS装置
  • 用于治疗大便失禁的SNS装置
  • 全球植入式神经刺激设备市场迷走神经刺激 (VNS) 细分市场（按类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 治疗癫痫的迷走神经刺激装置
  • 治疗忧郁症的迷走神经刺激装置
  • 全球植入式神经刺激设备市场，按类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 週边神经刺激（PNS）
  • 皮层刺激器
  • 新的神经刺激技术

第七章 区域和国家分析

  • 全球植入式神经刺激设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球植入式神经刺激设备市场：依国家、地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 植入式神经刺激设备市场：竞争格局
  • 植入式神经刺激设备市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • LivaNova PLC
  • Nevro Corp.
  • Axonics Inc.
  • NeuroPace Inc.
  • Bioness Inc.
  • Saluda Medical Pty Ltd.
  • SceneRay Co. Ltd.
  • NeuroMetrix Inc.
  • CURE Epilepsy
  • Synapse Biomedical Inc.
  • NeuroSigma Inc.
  • Nuvectra Corporation
  • MicroTransponder Inc.
  • Pain Management NYC
  • Curonix LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年植入式神经刺激设备市场：提供新机会的国家
  • 2029年植入式神经刺激设备市场：细分领域带来新机会
  • 2029年植入式神经刺激设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31973

Implantable neurostimulation devices are medical devices designed to deliver electrical stimulation to specific areas of the nervous system to treat various neurological and psychological conditions. These devices are surgically implanted into the body to modulate nerve activity, offering a sophisticated approach for managing conditions that may not respond adequately to medication alone, thereby enhancing patients' quality of life.

The primary types of implantable neurostimulation devices include spinal cord stimulation (SCS), gastric electric stimulation (GES), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and others. Spinal cord stimulation (SCS) therapy uses mild electrical currents to block pain signals from reaching the brain, providing effective management for chronic pain conditions. These devices are applied in treating pain management, Parkinson's disease, urinary and fecal incontinence, epilepsy, gastroparesis, and other conditions. They are used by various end-users, including hospitals, clinics, and ambulatory surgical centers.

The implantable neurostimulation devices market research report is one of a series of new reports from The Business Research Company that provides implantable neurostimulation devices market statistics, including implantable neurostimulation devices industry global market size, regional shares, competitors with a implantable neurostimulation devices market share, detailed implantable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable neurostimulation devices industry. This implantable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable neurostimulation devices market size has grown rapidly in recent years. It will grow from $8.68 $ billion in 2024 to $9.64 $ billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to increasing demand for non-pharmacological treatments, growing demand for minimally invasive procedures, growing geriatric population, increasing the wide range of psychiatric disorders, and increasing incidence of chronic diseases.

The implantable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $14.53 $ billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising prevalence of neurological disorders, rise in prevalence of lifestyle diseases, rising awareness, increase in spinal cord injuries, and increasing healthcare expenditure. Major trends in the forecast period include sensing technology, increasing advances in neurostimulation technologies, technologically advanced products, incorporating closed-loop systems, and integrating wireless technology.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the implantable neurostimulation device market in the future. Neurological disorders are conditions that impact the structure or function of the nervous system, leading to a range of symptoms such as paralysis, seizures, and cognitive impairments. Factors such as high blood pressure, developmental abnormalities, and trauma or injury contribute to higher detection rates of these disorders. Implantable neurostimulation devices are utilized to modulate nerve activity and alleviate symptoms when other treatments prove ineffective or insufficient. For example, in 2024, the Alzheimer's Association, a US-based non-profit organization, reported that approximately 6.9 million Americans aged 65 and older are living with Alzheimer's disease, with 73% being 75 years or older. This figure is projected to increase to 12.7 million by 2050. Consequently, the rising prevalence of neurological disorders is expected to propel the growth of the implantable neurostimulation device market.

Key players in the implantable neurostimulation devices market are developing advanced technologies, such as spinal cord stimulation (SCS) systems, to address chronic pain conditions. An SCS system is a medical device that uses electrical impulses to modulate nerve activity in the spinal cord, providing pain relief and improving patient quality of life when other treatments fail. For instance, in December 2022, Abbott, a U.S.-based medical device company, received FDA approval for the Eterna spinal cord stimulation (SCS) system. The Eterna SCS is the smallest rechargeable implantable spinal cord stimulator on the market, designed for maximum comfort. It features Abbott's BurstDR stimulation technology, which replicates natural brain firing patterns for enhanced pain relief and is preferred by 87% of patients over traditional tingling stimulation. Eterna requires as few as five recharges annually due to Xtend energy technology and supports full-body MRI scans with TotalScan technology. It is also adaptable to future advancements without replacement. Abbott's mobile app integration allows real-time tracking of battery life and charging status on iPhone devices.

In September 2023, Amber Therapeutics, a UK-based provider of neuromodulation therapies, acquired Bioinduction for an undisclosed amount. This acquisition gives Amber access to valuable hardware, expertise, and manufacturing experience, accelerating the development and commercialization of Amber-UI. Bioinduction is a UK-based manufacturer specializing in implantable neurostimulation devices.

Major companies operating in the implantable neurostimulation devices market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Dignity Health, St. Jude Medical LLC, LivaNova PLC, Nevro Corp., Axonics Inc., NeuroPace Inc., Bioness Inc., Saluda Medical Pty Ltd., SceneRay Co. Ltd., NeuroMetrix Inc., CURE Epilepsy, Synapse Biomedical Inc., NeuroSigma Inc., Nuvectra Corporation, MicroTransponder Inc., Pain Management NYC, Curonix LLC

North America was the largest region in the implantable neurostimulation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable neurostimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable neurostimulation devices market consists of sales of responsive neurostimulation systems, peripheral nerve stimulation systems, cerebral spinal fluid shunt systems and electroceutical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Neurostimulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable neurostimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable neurostimulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulation (SCS); Gastric Electric Stimulation (GES); Deep Brain Stimulation (DBS); Sacral Nerve Stimulation (SNS); Vagus Nerve Stimulation (VNS); Other Types
  • 2) By Application: Pain Management; Parkinson's Disease; Urinary And Fecal Incontinence; Epilepsy; Gastroparesis; Other Applications
  • 3) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Spinal Cord Stimulation (SCS): Rechargeable SCS Devices; Non-Rechargeable SCS Devices
  • 2) By Gastric Electric Stimulation (GES): Implantable Gastric Stimulators; Adjustable Gastric Stimulators
  • 3) By Deep Brain Stimulation (DBS): DBS Devices for Movement Disorders; DBS Devices for Psychiatric Disorders
  • 4) By Sacral Nerve Stimulation (SNS): SNS Devices for Urinary Incontinence; SNS Devices for Fecal Incontinence
  • 5) By Vagus Nerve Stimulation (VNS): VNS Devices for Epilepsy; VNS Devices for Depression
  • 6) By Other Types: Peripheral Nerve Stimulation (PNS); Cortical Stimulation Devices; Novel Neurostimulation Technologies
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Dignity Health; St. Jude Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Neurostimulation Devices Market Characteristics

3. Implantable Neurostimulation Devices Market Trends And Strategies

4. Implantable Neurostimulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Implantable Neurostimulation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Implantable Neurostimulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Implantable Neurostimulation Devices Market Growth Rate Analysis
  • 5.4. Global Implantable Neurostimulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Implantable Neurostimulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Implantable Neurostimulation Devices Total Addressable Market (TAM)

6. Implantable Neurostimulation Devices Market Segmentation

  • 6.1. Global Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Other Types
  • 6.2. Global Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Parkinson's Disease
  • Urinary And Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Other Applications
  • 6.3. Global Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • 6.4. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulation (SCS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rechargeable SCS Devices
  • Non-Rechargeable SCS Devices
  • 6.5. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Gastric Electric Stimulation (GES), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Gastric Stimulators
  • Adjustable Gastric Stimulators
  • 6.6. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Deep Brain Stimulation (DBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • DBS Devices for Movement Disorders
  • DBS Devices for Psychiatric Disorders
  • 6.7. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulation (SNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • SNS Devices for Urinary Incontinence
  • SNS Devices for Fecal Incontinence
  • 6.8. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulation (VNS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • VNS Devices for Epilepsy
  • VNS Devices for Depression
  • 6.9. Global Implantable Neurostimulation Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Nerve Stimulation (PNS)
  • Cortical Stimulation Devices
  • Novel Neurostimulation Technologies

7. Implantable Neurostimulation Devices Market Regional And Country Analysis

  • 7.1. Global Implantable Neurostimulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Implantable Neurostimulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Neurostimulation Devices Market

  • 8.1. Asia-Pacific Implantable Neurostimulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Neurostimulation Devices Market

  • 9.1. China Implantable Neurostimulation Devices Market Overview
  • 9.2. China Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Neurostimulation Devices Market

  • 10.1. India Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Neurostimulation Devices Market

  • 11.1. Japan Implantable Neurostimulation Devices Market Overview
  • 11.2. Japan Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Neurostimulation Devices Market

  • 12.1. Australia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Neurostimulation Devices Market

  • 13.1. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Neurostimulation Devices Market

  • 14.1. South Korea Implantable Neurostimulation Devices Market Overview
  • 14.2. South Korea Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Neurostimulation Devices Market

  • 15.1. Western Europe Implantable Neurostimulation Devices Market Overview
  • 15.2. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Neurostimulation Devices Market

  • 16.1. UK Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Neurostimulation Devices Market

  • 17.1. Germany Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Neurostimulation Devices Market

  • 18.1. France Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Neurostimulation Devices Market

  • 19.1. Italy Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Neurostimulation Devices Market

  • 20.1. Spain Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Neurostimulation Devices Market

  • 21.1. Eastern Europe Implantable Neurostimulation Devices Market Overview
  • 21.2. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Neurostimulation Devices Market

  • 22.1. Russia Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Neurostimulation Devices Market

  • 23.1. North America Implantable Neurostimulation Devices Market Overview
  • 23.2. North America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Neurostimulation Devices Market

  • 24.1. USA Implantable Neurostimulation Devices Market Overview
  • 24.2. USA Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Neurostimulation Devices Market

  • 25.1. Canada Implantable Neurostimulation Devices Market Overview
  • 25.2. Canada Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Neurostimulation Devices Market

  • 26.1. South America Implantable Neurostimulation Devices Market Overview
  • 26.2. South America Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Neurostimulation Devices Market

  • 27.1. Brazil Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Neurostimulation Devices Market

  • 28.1. Middle East Implantable Neurostimulation Devices Market Overview
  • 28.2. Middle East Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Neurostimulation Devices Market

  • 29.1. Africa Implantable Neurostimulation Devices Market Overview
  • 29.2. Africa Implantable Neurostimulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Implantable Neurostimulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Implantable Neurostimulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Neurostimulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Neurostimulation Devices Market Competitive Landscape
  • 30.2. Implantable Neurostimulation Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Dignity Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. St. Jude Medical LLC Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Neurostimulation Devices Market Other Major And Innovative Companies

  • 31.1. LivaNova PLC
  • 31.2. Nevro Corp.
  • 31.3. Axonics Inc.
  • 31.4. NeuroPace Inc.
  • 31.5. Bioness Inc.
  • 31.6. Saluda Medical Pty Ltd.
  • 31.7. SceneRay Co. Ltd.
  • 31.8. NeuroMetrix Inc.
  • 31.9. CURE Epilepsy
  • 31.10. Synapse Biomedical Inc.
  • 31.11. NeuroSigma Inc.
  • 31.12. Nuvectra Corporation
  • 31.13. MicroTransponder Inc.
  • 31.14. Pain Management NYC
  • 31.15. Curonix LLC

32. Global Implantable Neurostimulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Neurostimulation Devices Market

34. Recent Developments In The Implantable Neurostimulation Devices Market

35. Implantable Neurostimulation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Implantable Neurostimulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Implantable Neurostimulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Implantable Neurostimulation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer